Neurooncology: 2023 update

Michel Mittelbronn

Neuromuscular disease: 2023 update

Marta Margeta

Multiple sclerosis: 2023 update

Tanja Kuhlmann, Jack Antel

Neurotrauma: 2022 update

David S. Priemer, Daniel P. Perl


Golgi localization of SARS-CoV-2 spike protein and interaction with furin in cerebral COVID-19 microangiopathy: a clue to the central nervous system involvement?

Susana Boluda, Karima Mokhtari, Bruno Mégarbane, Djillali Annane, Bertrand Mathon, Albert Cao, Clovis Adam, Alexandre Androuin, Franck Bielle, Guy Brochier, Frédéric Charlotte, Lydia Chougar, Khalid Hamid El Hachimi, Marc Eloit, Stéphane Haïk, Dominique Hervé, Amal Kasri, Valentin Leducq, Stéphane Lehéricy, Etienne Levavasseur, Christian Lobsiger, Geoffroy Lorin de La Grandmaison, Isabelle Malet, Isabelle Malissin, Stéphane Marot, Serge Marty, Philippe Pérot, Isabelle Plu, Annick Prigent, Lev Stimmer, Marie-Claude Potier, Anne-Geneviève Marcelin, Benoît Delatour, Charles Duyckaerts, Danielle Seilhean

Post-mortem neuropathologic examination of a 6-case series of CAR T-cell treated patients

Núria Vidal Robau, Gabriela Caballero, Ivan Archilla, Andrea Ladino, Sara Fernández, Valentín Ortiz-Maldonado, Montserrat Rovira, Marta Gómez-Hernando, Julio Delgado, María Suárez-Lledó, Carlos Fernández de Larrea, Olga Balagué, Gerard Frigola, Abel Muñoz, Estrella Ortiz, Teresa Ribalta, Miguel J. Martinez, Maria Angeles-Marcos, Marta Español-Rego, Azucena González, Daniel Benitez-Ribas, Eugenia Martinez-Hernandez, Pedro Castro, Iban Aldecoa


62nd Annual Meeting of the Canadian Association of Neuropathologists - Association canadienne des neuropathologistes (CANP-ACNP)

The Canadian Association of Neuropathologists - Association canadienne des neuropathologistes (CANP-ACNP)

Dear colleagues,

let’s talk about sustainability today.

The first three years of our successful pioneering work under the lead of Werner Paulus is done, heavy tasks have been lifted mainly by the team in Münster with the strong support of many colleagues of the current editorial board. Thank you all so much for your efforts!

During multiple application processes (e.g. pubmed, medline) to increase the visibility of FNP, it became however more and more evident that FNP had to come up with a vision how to make FNP sustainable not only with regard to the expected increase in workload of scientific paper handling, but also the organization of IT infrastructure, legal or logistic issues – just to name a few – affecting the entire production line without having a publisher in our back (which is of course one of our key values).

Therefore, the decision was taken to appoint a second Editor-in-chief in a different country. With this, I would like to express my gratitude to the entire FNP editorial board for their trust and David Louis for organizing the election process – I am full of energy to serve FNP as additional Editor-in-chief from now on, together with Werner Paulus. As also multiple important international neuropathology societies have recently expressed their trust in our concept and values, the FNP board feels the high responsibility in further promoting the most important information in the central academic pillars – diagnostic, research and teaching – of our domain. My aim is to be a highly accessible and reactive Editor, so don’t hesitate to discuss personally with me or share new ideas important for the positive development of our domain and journal. Over the next weeks, we aim at paralleling the infrastructures of FNP to be ready for the expected increase in workload associated with our goal to be even more visible in pubmed and other related repositories in the near future.

Michel Mittelbronn
Editor, Free Neuropathology


Why is the journal called Free Neuropathology and what exactly does free mean?

Free for authors means that there is no article processing fee.
Free for readers means that the journal is published open-access without paywalls or any other restrictions of access. Together, these two features constitute what is called diamond open access. There is no revenue, no financial donation, no commercial advertising and no budget. Any expenses (editorial office, travelling, promotion, software, technical infrastructure etc.) are covered by academic institutions. To achieve this goal, we use open-source software such as Open Journal Systems (OJS).
Free from publisher means that the journal takes care of all activities that traditionally are carried out by publishers, including but not restricted to copyediting, layout, permanent archiving of papers, maintenance of website, and promotion. This is based on the insight that commercial publishers are primarily interested in profit rather than in science, which has led to an economical and ethical crisis in scientific publishing. We feel that we can perform these activities more efficiently and more passionately than publishers do. For example, we are able to publish papers in the final format within three days after acceptance, including careful copyediting and layout. This is accomplished by our dedicated layout/copyediting board of enthusiastic young colleagues.
Free formatting means that the journal refrains from exuberant formal requirements and extremely detailed instructions for authors, which abound in many scientific journal. However, the journal places much emphasis on a professional and appealing appearance of papers and supports consistent formatting within the paper according to authors’ preferences.
Free opinion means that in addition to traditional categories of papers such as original papers, review articles and letters, the journal publishes opinion pieces expressing personal or minority (yet scientifically founded) views, and that it encourages frank scholarly discussion among authors and readers, among the editorial board members, and among scientists and the public. On our website we utilize the open source software called which introduces a sentence-level annotation layer over any paper: comments from anyone about anything and visible for anyone.

If you’d like to make up your own mind about this project, head to the journal’s website at where you’ll find out more about our publication model, our editorial board, FAQ, free access to all papers published so far, and more.

If you wish to subscribe to this newsletter, please
send an email to